Jörg Kumbrink

976 total citations
37 papers, 325 citations indexed

About

Jörg Kumbrink is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jörg Kumbrink has authored 37 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Jörg Kumbrink's work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Jörg Kumbrink is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Jörg Kumbrink collaborates with scholars based in Germany, United States and Netherlands. Jörg Kumbrink's co-authors include Thomas Kirchner, Andreas Jung, Jens Neumann, Thomas Kirchner, Peter Seizer, Britta Walker-Allgaier, Reinhard Kandolf, Karin Anne Lydia Mueller, Harald F. Langer and Meinrad Gawaz and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Jörg Kumbrink

35 papers receiving 321 citations

Peers

Jörg Kumbrink

ONCOL

PRM

CCM

Matthew Kosel United States

Chao Cheng China

Ankit Patel United States

Patricia Q. Rodriguez Sweden

Hui Hua Li Singapore

Alexandra H. Besser United States

Wenjuan Yu China

Jin Gu Cho South Korea

Ewa Zembala‐Nożyńska Poland

Matthew Kosel United States

Jörg Kumbrink

72 ×0.7

ONCOL

123 ×1.4

70 ×0.8

66 ×0.8

PRM

46 ×0.6

CCM

Citations per year, relative to Jörg Kumbrink Jörg Kumbrink (= 1×) peers Matthew Kosel

Countries citing papers authored by Jörg Kumbrink

Since Specialization

Citations

This map shows the geographic impact of Jörg Kumbrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Kumbrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Kumbrink more than expected).

Fields of papers citing papers by Jörg Kumbrink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Kumbrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Kumbrink. The network helps show where Jörg Kumbrink may publish in the future.

Co-authorship network of co-authors of Jörg Kumbrink

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Kumbrink. A scholar is included among the top collaborators of Jörg Kumbrink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Kumbrink. Jörg Kumbrink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michl, Marlies, Frederick Klauschen, Thomas Kirchner, et al.. (2024). Identification of a gene expression signature associated with brain metastasis in colorectal cancer. Clinical & Translational Oncology. 26(8). 1886–1895. 3 indexed citations

Heinrich, Kathrin, Andreas Jung, C. Benedikt Westphalen, et al.. (2024). Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center. International Journal of Molecular Sciences. 25(4). 2345–2345. 3 indexed citations

Kumbrink, Jörg, et al.. (2024). The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches. Cancers. 17(1). 48–48. 1 indexed citations

Jurinović, Vindi, Jörg Kumbrink, Thomas Kirchner, et al.. (2024). TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer. Clinical & Experimental Metastasis. 41(5). 687–697.

Kumbrink, Jörg, Andreas Bräuninger, Ralf Marienfeld, et al.. (2024). Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting. Pathology & Oncology Research. 30. 1611590–1611590. 1 indexed citations

Lechner, Axel, et al.. (2024). Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract. Frontiers in Oncology. 14. 1364958–1364958. 1 indexed citations

Kumbrink, Jörg, Christoph Walz, G. Drexler, et al.. (2022). Analysis of genetic variants of frequently mutated genes in human papillomavirus‐negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell‐free DNA. Journal of Oral Pathology and Medicine. 51(8). 738–746. 15 indexed citations

Käsmann, Lukas, Julian Taugner, Chukwuka Eze, et al.. (2022). Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study. Translational Lung Cancer Research. 11(7). 1503–1509. 3 indexed citations

Stahler, Arndt, Volker Heinemann, Kathrin Heinrich, et al.. (2021). Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial). European Journal of Cancer. 157. 71–80. 4 indexed citations

10.

Schober, Andreas, Farima Zahedi, Mengyu Zhu, et al.. (2021). MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions. Circulation. 144(13). 1059–1073. 35 indexed citations

11.

Nowak, Elisabeth, Andreas Böck, Michael Salvermoser, et al.. (2021). Mitogen‐activated protein kinase signaling in childhood asthma development and environment‐mediated protection. Pediatric Allergy and Immunology. 33(1). e13657–e13657. 17 indexed citations

12.

Jurinović, Vindi, Elise Pretzsch, Jörg Kumbrink, et al.. (2021). The association of immunosurveillance and distant metastases in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 147(11). 3333–3341. 9 indexed citations

13.

Michl, Marlies, Jörg Kumbrink, Tobias S. Schiergens, et al.. (2020). Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(4). 695–705. 7 indexed citations

14.

Giehl, Kathrin, Jörg Kumbrink, Judith Fischer, et al.. (2020). Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle. Acta Dermato Venereologica. 100(15). adv00241–adv00241. 1 indexed citations

15.

Fliefel, Riham, et al.. (2020). Bifunctional effect of Zoledronic Acid (ZA) on human mesenchymal stem cells (hMSCs) based on the concentration level. Journal of Stomatology Oral and Maxillofacial Surgery. 121(6). 634–641. 12 indexed citations

16.

Heinemann, Volker, Jutta Engel, G. Schubert-Fritschle, et al.. (2020). Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival. International Journal of Cancer. 148(8). 1919–1927. 17 indexed citations

17.

Heinzmann, David, Karin Klingel, Karin Müller, et al.. (2019). Mitochondrial Dynamics in Tachycardiomyopathy. Cellular Physiology and Biochemistry. 52(3). 435–438. 3 indexed citations

18.

Kauffmann‐Guerrero, Diego, Kathrin Kahnert, Jörg Kumbrink, et al.. (2018). Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib. Clinical Lung Cancer. 20(1). 59–62. 10 indexed citations

19.

Mueller, Karin Anne Lydia, David Heinzmann, Karin Klingel, et al.. (2017). Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. Journal of the American College of Cardiology. 69(17). 2160–2172. 76 indexed citations

20.

Stahler, Arndt, Sebastian Stintzing, Dominik Paul Modest, et al.. (2016). Targeting FGF2 expression against chemoresistance in colorectal cancer (CRC) cell lines - a potential prognostic biomarker in patients with metastatic colorectal cancer (mCRC) treated with FUFIRI or mIrOx (FIRE1). Annals of Oncology. 27. vi156–vi156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact